• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.大鼠CD59及嵌合蛋白CD59-Crry在毕赤酵母中作为活性可溶性蛋白的表达及功能分析
Immunology. 2000 Jan;99(1):46-53. doi: 10.1046/j.1365-2567.2000.00945.x.
2
Production of the rat complement regulator, Crry, as an active soluble protein in Pichia pastoris.在毕赤酵母中作为活性可溶性蛋白生产大鼠补体调节蛋白Crry。
Arch Biochem Biophys. 1997 May 15;341(2):347-52. doi: 10.1006/abbi.1997.9989.
3
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).补体调节蛋白(CRPs)的抑制会加重实验性自身免疫性前葡萄膜炎(EAAU)。
J Immunol. 2006 Jun 15;176(12):7221-31. doi: 10.4049/jimmunol.176.12.7221.
4
Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.Crry和CD59调节大鼠肾小球上皮细胞中的补体,并被被动型Heymann肾炎的致肾炎抗体所抑制。
J Immunol. 1995 Apr 1;154(7):3437-43.
5
Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.眼内慢性低水平补体激活由眼内补体调节蛋白控制。
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3492-502.
6
Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.大鼠肾小球中的补体调节:Crry和CD59调节肾小球系膜细胞和内皮细胞中的补体。
Kidney Int. 1995 Aug;48(2):412-21. doi: 10.1038/ki.1995.309.
7
Production and functional characterization of a soluble recombinant form of mouse CD59.小鼠CD59可溶性重组形式的产生及功能特性分析
Immunology. 2000 Feb;99(2):326-32. doi: 10.1046/j.1365-2567.2000.00936.x.
8
Glomerular complement regulation is overwhelmed in passive Heymann nephritis.在被动型海曼肾炎中,肾小球补体调节功能不堪重负。
Kidney Int. 2001 Sep;60(3):900-9. doi: 10.1046/j.1523-1755.2001.060003900.x.
9
CD59 protects rat kidney from complement mediated injury in collaboration with crry.CD59与Crry协同保护大鼠肾脏免受补体介导的损伤。
Kidney Int. 2000 Oct;58(4):1569-79. doi: 10.1046/j.1523-1755.2000.00318.x.
10
Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.转基因小鼠中重组可溶性Crry在肾脏、中枢神经系统和胰腺中的过表达。一种防止补体介导损伤的新方法。
Immunopharmacology. 1999 May;42(1-3):245-54. doi: 10.1016/s0162-3109(99)00010-7.

引用本文的文献

1
The Production of Complement Inhibitor Proteins in Mammalian Cell Lines-Light at the End of the Tunnel?哺乳动物细胞系中补体抑制蛋白的生产——曙光在前?
Biomedicines. 2024 Mar 14;12(3):646. doi: 10.3390/biomedicines12030646.
2
On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.曼氏血吸虫中的三指蛋白结构域折叠和 CD59 样蛋白。
PLoS Negl Trop Dis. 2013 Oct 24;7(10):e2482. doi: 10.1371/journal.pntd.0002482. eCollection 2013.
3
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.补体受体2介导的补体抑制剂靶向作用于补体激活部位。
J Clin Invest. 2003 Jun;111(12):1875-85. doi: 10.1172/JCI17348.
4
Bacterial expression and membrane targeting of the rat complement regulator Crry: a new model anticomplement therapeutic.大鼠补体调节蛋白Crry的细菌表达及膜靶向作用:一种新型抗补体治疗模型
Protein Sci. 2002 Oct;11(10):2512-21. doi: 10.1110/ps.0212402.
5
Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.将补体调节蛋白与免疫球蛋白结构域偶联可产生在体内具有延长半衰期的有效抗补体试剂。
Clin Exp Immunol. 2002 Aug;129(2):198-207. doi: 10.1046/j.1365-2249.2002.01924.x.

本文引用的文献

1
Targeting of functional antibody-CD59 fusion proteins to a cell surface.将功能性抗体 - CD59融合蛋白靶向至细胞表面。
J Clin Invest. 1999 Jan;103(1):55-61. doi: 10.1172/JCI4607.
2
Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).人衰变加速因子(CD55)大鼠类似物的分子克隆与功能特性分析
J Immunol. 1998 Nov 15;161(10):5695-703.
3
Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.补体调节的抑制是活动性海曼肾炎发病机制的关键。
J Exp Med. 1998 Oct 5;188(7):1353-8. doi: 10.1084/jem.188.7.1353.
4
Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.过表达作为可溶性蛋白的补体抑制剂Crry的转基因小鼠可免受抗体诱导的肾小球损伤。
J Exp Med. 1998 Oct 5;188(7):1321-31. doi: 10.1084/jem.188.7.1321.
5
Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.用可溶性小鼠补体抑制剂Crry-Ig阻断抗体诱导的肾小球肾炎。
J Immunol. 1998 May 1;160(9):4553-60.
6
Production of the rat complement regulator, Crry, as an active soluble protein in Pichia pastoris.在毕赤酵母中作为活性可溶性蛋白生产大鼠补体调节蛋白Crry。
Arch Biochem Biophys. 1997 May 15;341(2):347-52. doi: 10.1006/abbi.1997.9989.
7
A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities.
J Immunol. 1997 Mar 15;158(6):2872-81.
8
Overexpression of Crry protects mesangial cells from complement-mediated injury.Crry的过表达可保护系膜细胞免受补体介导的损伤。
J Am Soc Nephrol. 1997 Feb;8(2):223-33. doi: 10.1681/ASN.V82223.
9
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.缺血性骨骼肌的再灌注损伤是由天然抗体和补体介导的。
J Exp Med. 1996 May 1;183(5):2343-8. doi: 10.1084/jem.183.5.2343.
10
A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.重组可溶性CD46的体内功能分析及与重组可溶性CD55和CD35体外形式的比较。
Eur J Immunol. 1996 Mar;26(3):578-85. doi: 10.1002/eji.1830260312.

大鼠CD59及嵌合蛋白CD59-Crry在毕赤酵母中作为活性可溶性蛋白的表达及功能分析

Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

作者信息

Quigg R J, He C, Hack B K, Alexander J J, Morgan B P

机构信息

Department of Medicine, Section of Nephrology, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Immunology. 2000 Jan;99(1):46-53. doi: 10.1046/j.1365-2567.2000.00945.x.

DOI:10.1046/j.1365-2567.2000.00945.x
PMID:10651940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2327136/
Abstract

Crry (CR1-related gene/protein) is a rodent complement regulator that inhibits C3 convertases. CD59 is a conserved protein inhibitor active towards C8 and C9. We have previously produced rat Crry as a recombinant soluble (rs) protein in Pichia pastoris. In this study we produced functionally active rat rsCD59 and a chimeric rsCD59-Crry protein in P. pastoris. The GPI anchor addition site of rat CD59 (Asn-79) was replaced either by a stop codon to produce rsCD59, or with the sequence of the first five short consensus repeats of Crry to produce rsCD59-Crry. Proteins were generated by fermentation and purified by affinity chromatography on an anti-CD59 column. In a standard classical pathway haemolysis assay, all three rs proteins had inhibitory activity, with 50% inhibition at 0.5 microM (rsCrry and rsCD59-Crry) and 4.4 microM (rsCD59). In an assay examining inhibition of C5b-9, in which C5b-7 was first formed, followed by purified C8 and C9, rsCD59 and rsCD59-Crry were active with 50% inhibition at 0.8 microM (rsCD59-Crry) and 1.3 microM (rsCD59). The degree of inhibition was independent of whether the C8 and C9 were of rat or human origin. Therefore, we have produced rsCD59 and rsCD59-Crry in P. pastoris. The rsCD59 retains its inhibitory activity towards C5b-9, while rsCD59-Crry appears to have the combined activities of Crry and CD59. In a haemolytic assay, the inclusion of CD59 to Crry is of no additional benefit to Crry, which may illustrate the overall importance of the C3 convertase step. Yet, inclusion of Crry to CD59 increases the potency of CD59 towards C5b-9.

摘要

Crry(CR1相关基因/蛋白)是一种抑制C3转化酶的啮齿动物补体调节因子。CD59是一种对C8和C9有活性的保守蛋白抑制剂。我们之前已在毕赤酵母中制备出大鼠Crry作为重组可溶性(rs)蛋白。在本研究中,我们在毕赤酵母中制备了具有功能活性的大鼠rsCD59和嵌合rsCD59-Crry蛋白。大鼠CD59的糖基磷脂酰肌醇(GPI)锚定添加位点(Asn-79)要么被终止密码子取代以产生rsCD59,要么被Crry的前五个短共有重复序列取代以产生rsCD59-Crry。通过发酵产生蛋白,并在抗CD59柱上通过亲和层析进行纯化。在标准经典途径溶血试验中,所有三种rs蛋白均具有抑制活性,rsCrry和rsCD59-Crry在0.5微摩尔时抑制率达50%,rsCD59在4.4微摩尔时抑制率达50%。在一项检测对C5b-9抑制作用的试验中,先形成C5b-7,随后加入纯化的C8和C9,rsCD59和rsCD59-Crry具有活性,rsCD59-Crry在0.8微摩尔时抑制率达50%,rsCD59在1.3微摩尔时抑制率达50%。抑制程度与C8和C9是大鼠来源还是人来源无关。因此,我们已在毕赤酵母中制备出rsCD59和rsCD59-Crry。rsCD59保留了其对C5b-9的抑制活性,而rsCD59-Crry似乎具有Crry和CD59的联合活性。在溶血试验中,在Crry中加入CD59对Crry并无额外益处,这可能说明了C3转化酶步骤的总体重要性。然而,在CD59中加入Crry会增加CD59对C5b-9的效力。